系统性硬化症患者的眼部表现
Ocular manifestations in patients with systemic sclerosis.
作者信息
Kozikowska Małgorzata, Luboń Wojciech, Kucharz Eugeniusz J, Mrukwa-Kominek Ewa
机构信息
Department of Ophthalmology, Professor K. Gibinski University Clinical Center of the Medical University of Silesia, Katowice, Poland.
Department of Ophthalmology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, Katowice, Poland.
出版信息
Reumatologia. 2020;58(6):401-406. doi: 10.5114/reum.2020.102004. Epub 2020 Dec 23.
Abstract
Systemic sclerosis (SSc) is a rare, chronic autoimmune disease with unknown etiology. Its prominent features are fibrosis, vasculopathy and impaired immune response. Disease can also affect eyes leading to various findings in ophthalmological examination. The objective of this study was to determine the prevalence and type of ocular involvement in patients with SSc. A systematic literature review was conducted using electronic databases. A combination of following keywords was used: "systemic sclerosis" and ophthalmology-related search terms, including the keywords "eye", "ocular" and "ophthalmic". In conclusion, eyelid and conjunctival abnormalities and dry eye disease are among the most common ocular manifestations of SSc. Their diversity is connected to complexity of the disease.
摘要
系统性硬化症（SSc）是一种病因不明的罕见慢性自身免疫性疾病。其突出特征为纤维化、血管病变和免疫反应受损。该疾病还可累及眼睛，导致眼科检查出现各种结果。本研究的目的是确定系统性硬化症患者眼部受累的患病率及类型。我们使用电子数据库进行了一项系统的文献综述。使用了以下关键词组合：“系统性硬化症”以及与眼科相关的检索词，包括关键词“眼睛”“眼部的”和“眼科的”。总之，眼睑和结膜异常以及干眼症是系统性硬化症最常见的眼部表现。它们的多样性与该疾病的复杂性相关。
相似文献
1
Ocular manifestations in patients with systemic sclerosis.系统性硬化症患者的眼部表现
Reumatologia. 2020;58(6):401-406. doi: 10.5114/reum.2020.102004. Epub 2020 Dec 23.
2
Ocular involvement in systemic sclerosis: A systematic literature review, it's not all scleroderma that meets the eye.眼部受累的系统性硬化症：系统文献回顾，并非所有硬皮病都表现在眼部。
Semin Arthritis Rheum. 2019 Aug;49(1):119-125. doi: 10.1016/j.semarthrit.2018.12.007. Epub 2018 Dec 28.
3
Ocular Manifestation in Systemic Sclerosis-A Literature Review.系统性硬化症的眼部表现——文献综述
Life (Basel). 2024 May 13;14(5):627. doi: 10.3390/life14050627.
4
A Wide Spectrum of Ocular Manifestations Signify Patients with Systemic Sclerosis.全身性硬皮病患者的眼部表现多种多样。
Ocul Immunol Inflamm. 2021 Jan 2;29(1):81-89. doi: 10.1080/09273948.2019.1657467. Epub 2019 Oct 2.
5
Prevalence of ocular manifestations in systemic sclerosis patients.系统性硬化症患者眼部表现的患病率。
Arch Med Sci. 2013 Dec 30;9(6):1107-13. doi: 10.5114/aoms.2013.39217. Epub 2013 Nov 29.
6
Ocular Involvement in Systemic Sclerosis: Updated Review and New Insights on Microvascular Impairment.系统性硬化症的眼部受累：微血管损伤的最新综述与新见解
Ocul Immunol Inflamm. 2024 Nov;32(9):2209-2216. doi: 10.1080/09273948.2024.2308030. Epub 2024 Mar 11.
7
The role of platelets in autoimmunity, vasculopathy, and fibrosis: Implications for systemic sclerosis.血小板在自身免疫、血管病变和纤维化中的作用：对系统性硬化症的影响。
Semin Arthritis Rheum. 2017 Dec;47(3):409-417. doi: 10.1016/j.semarthrit.2017.05.004. Epub 2017 May 23.
8
The role of endothelial cells in the vasculopathy of systemic sclerosis: A systematic review.系统性硬皮病血管病变中内皮细胞的作用：系统评价。
Autoimmun Rev. 2017 Aug;16(8):774-786. doi: 10.1016/j.autrev.2017.05.024. Epub 2017 May 29.
9
Ocular manifestations of rheumatic diseases.风湿性疾病的眼部表现。
Int Ophthalmol. 2020 Feb;40(2):503-510. doi: 10.1007/s10792-019-01183-9. Epub 2019 Oct 3.
10
Colonic Manifestations and Complications Are Relatively Under-Reported in Systemic Sclerosis: A Systematic Review.系统性硬化症中结直肠表现和并发症的报道相对较少：系统评价。
Am J Gastroenterol. 2019 Dec;114(12):1847-1856. doi: 10.14309/ajg.0000000000000397.
引用本文的文献
1
Evaluation of the choroidal vascularity index and choroidal thickness in patients with systemic sclerosis.系统性硬化症患者脉络膜血管指数和脉络膜厚度的评估
Int Ophthalmol. 2025 May 8;45(1):181. doi: 10.1007/s10792-025-03536-z.
2
A Comprehensive Exploration of the Biological Effects of Adipose-Derived Stem Cells in the Treatment of Systemic Sclerosis.脂肪来源干细胞治疗系统性硬化症的生物学效应综合探究
Cells. 2025 Mar 19;14(6):458. doi: 10.3390/cells14060458.
3
Assessment of interocular symmetry of choroidal vascularity index and thickness in patients with systemic sclerosis: a prospective study.系统性硬化症患者脉络膜血管指数和厚度的眼间对称性评估：一项前瞻性研究。
Front Med (Lausanne). 2025 Jan 16;11:1513679. doi: 10.3389/fmed.2024.1513679. eCollection 2024.
4
Dacryoadenitis as a Rare Initial Presentation in a Patient with Suspected Crest Syndrome.泪腺炎作为疑似CREST综合征患者罕见的首发表现。
Eur J Case Rep Intern Med. 2024 Sep 19;11(10):004801. doi: 10.12890/2024_004801. eCollection 2024.
5
A Comprehensive Review of Ocular Manifestations in Systemic Diseases.系统性疾病眼部表现的综合综述
Cureus. 2024 Jul 29;16(7):e65693. doi: 10.7759/cureus.65693. eCollection 2024 Jul.
6
Ocular Manifestation in Systemic Sclerosis-A Literature Review.系统性硬化症的眼部表现——文献综述
Life (Basel). 2024 May 13;14(5):627. doi: 10.3390/life14050627.
7
Retinal Vascular Abnormalities and Clinical Parameters in Systemic Sclerosis.系统性硬化症中的视网膜血管异常与临床参数
J Clin Med. 2024 May 7;13(10):2738. doi: 10.3390/jcm13102738.
8
Retinal Microvasculature in Systemic Sclerosis Patients and the Correlation between Nailfold Capillaroscopic Findings and Optical Coherence Angiography Results.系统性硬化症患者的视网膜微血管以及甲襞毛细血管镜检查结果与光学相干血管造影结果之间的相关性
J Clin Med. 2024 Mar 30;13(7):2025. doi: 10.3390/jcm13072025.
9
Macular choroidal thickness, volume, and vascularity index in patients with systemic sclerosis.系统性硬化症患者的黄斑脉络膜厚度、体积和血管指数。
Graefes Arch Clin Exp Ophthalmol. 2024 May;262(5):1475-1487. doi: 10.1007/s00417-023-06342-4. Epub 2023 Dec 22.
10
Paracentral acute middle maculopathy in systemic sclerosis and subsequent branch retinal artery occlusion.系统性硬化症中的中心旁急性黄斑病变及随后的视网膜分支动脉阻塞
Am J Ophthalmol Case Rep. 2023 Nov 4;32:101955. doi: 10.1016/j.ajoc.2023.101955. eCollection 2023 Dec.
本文引用的文献
1
Plasma Glycosaminoglycan Profiles in Systemic Sclerosis: Associations with MMP-3, MMP-10, TIMP-1, TIMP-2, and TGF-Beta.系统性硬化症患者的血浆糖胺聚糖谱：与 MMP-3、MMP-10、TIMP-1、TIMP-2 和 TGF-β的相关性。
Biomed Res Int. 2020 Apr 21;2020:6416514. doi: 10.1155/2020/6416514. eCollection 2020.
2
A Wide Spectrum of Ocular Manifestations Signify Patients with Systemic Sclerosis.全身性硬皮病患者的眼部表现多种多样。
Ocul Immunol Inflamm. 2021 Jan 2;29(1):81-89. doi: 10.1080/09273948.2019.1657467. Epub 2019 Oct 2.
3
Evaluation of choroidal substructure perfusion in patients affected by systemic sclerosis: an optical coherence tomography angiography study.评估系统性硬化症患者脉络膜亚结构灌注：光学相干断层扫描血管造影研究。
Scand J Rheumatol. 2020 Mar;49(2):141-145. doi: 10.1080/03009742.2019.1641616. Epub 2019 Sep 17.
4
Corneal Manifestations of Systemic Sclerosis.系统性硬化症的角膜表现。
Ocul Immunol Inflamm. 2019;27(6):968-977. doi: 10.1080/09273948.2018.1489556. Epub 2018 Jul 17.
5
Systemic sclerosis sine scleroderma.无硬皮病的系统性硬化症。
Adv Clin Exp Med. 2017 Aug;26(5):875-880. doi: 10.17219/acem/64334.
6
Very Early Systemic Sclerosis and Pre-systemic Sclerosis: Definition, Recognition, Clinical Relevance and Future Directions.极早期系统性硬化症和前系统性硬化症：定义、识别、临床相关性及未来方向
Curr Rheumatol Rep. 2017 Sep 18;19(10):65. doi: 10.1007/s11926-017-0684-2.
7
Association between objective signs and subjective symptoms of dry eye disease in patients with systemic sclerosis.干燥综合征患者的干眼疾病的客观体征与主观症状之间的关系。
Rheumatol Int. 2017 Nov;37(11):1835-1845. doi: 10.1007/s00296-017-3794-2. Epub 2017 Sep 7.
8
Pathogenesis of systemic sclerosis-current concept and emerging treatments.系统性硬化症的发病机制——当前概念与新兴治疗方法
Immunol Res. 2017 Aug;65(4):790-797. doi: 10.1007/s12026-017-8926-y.
9
Systemic sclerosis.系统性硬化症。
Lancet. 2017 Oct 7;390(10103):1685-1699. doi: 10.1016/S0140-6736(17)30933-9. Epub 2017 Apr 13.
10
Evaluation of choroidal thickness in patients with scleroderma.硬皮病患者脉络膜厚度的评估。
Eye (Lond). 2016 Apr;30(4):588-92. doi: 10.1038/eye.2015.287. Epub 2016 Jan 22.
Zotero 插件